Total Payments
$2,063
2024 Payments
$121.62
Companies
21
Transactions
130
Medicare Patients
1,583
Medicare Billing
$219,584
Payment Breakdown by Category
Food & Beverage$1,844 (89.4%)
Education$201.52 (9.8%)
Travel$17.69 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,844 | 125 | 89.4% |
| Education | $201.52 | 4 | 9.8% |
| Travel and Lodging | $17.69 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $541.83 | 49 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $272.35 | 19 | $0 (2018) |
| PFIZER INC. | $242.36 | 14 | $0 (2024) |
| Amgen Inc. | $155.01 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $135.79 | 2 | $0 (2021) |
| Incyte Corporation | $111.08 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $109.33 | 7 | $0 (2018) |
| Celgene Corporation | $106.79 | 6 | $0 (2018) |
| Janssen Biotech, Inc. | $78.71 | 6 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $74.39 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.62 | 3 | Incyte Corporation ($83.99) |
| 2023 | $134.04 | 6 | Karyopharm Therapeutics Inc. ($41.87) |
| 2022 | $18.67 | 1 | Karyopharm Therapeutics Inc. ($18.67) |
| 2021 | $231.83 | 3 | AstraZeneca Pharmaceuticals LP ($120.80) |
| 2019 | $45.67 | 3 | Genentech USA, Inc. ($45.67) |
| 2018 | $517.00 | 38 | Genentech USA, Inc. ($182.88) |
| 2017 | $994.24 | 76 | Genentech USA, Inc. ($313.28) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 2 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $12.20 | General |
| 04/11/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2018 | Janssen Biotech, Inc. | Erleada (Drug), ZYTIGA, DARZALEX | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Oncology | ||||||
| 04/05/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: BioOncology | ||||||
| 04/05/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: BioOncology | ||||||
| 04/03/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 03/16/2018 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 03/13/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: BioOncology | ||||||
| 03/01/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: BioOncology | ||||||
| 03/01/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: BioOncology | ||||||
| 02/28/2018 | Amgen Inc. | Neulasta (Biological), NEUPOGEN, Vectibix | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Oncology | ||||||
| 02/27/2018 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Oncology | ||||||
| 02/26/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: Oncology | ||||||
| 02/22/2018 | PFIZER INC. | SUTENT (Drug), XALKORI, INLYTA | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 02/20/2018 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: ONCOLOGY | ||||||
| 02/16/2018 | Genentech USA, Inc. | Avastin (Biological), Alecensa, TECENTRIQ | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: BioOncology | ||||||
| 02/15/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Oncology | ||||||
| 02/12/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.57 | General |
| Category: Oncology | ||||||
| 02/08/2018 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: BioOncology | ||||||
| 02/08/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: BioOncology | ||||||
| 02/07/2018 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 02/01/2018 | Genentech USA, Inc. | Avastin (Biological), Alecensa | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 367 | 649 | $253,845 | $64,190 |
| 2022 | 10 | 396 | 632 | $204,984 | $49,948 |
| 2021 | 10 | 423 | 780 | $206,210 | $53,921 |
| 2020 | 8 | 397 | 792 | $185,562 | $51,526 |
Total Patients
1,583
Total Services
2,853
Medicare Billing
$219,584
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 17 | $9,554 | $2,678 | 28.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $7,185 | $1,913 | 26.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 12 | 15 | $4,470 | $1,252 | 28.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $3,509 | $972.95 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 62 | 96 | $864.00 | $279.76 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 264 | $77,616 | $21,550 | 27.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 74 | 243 | $48,600 | $14,122 | 29.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 47 | 54 | $16,659 | $4,461 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 67 | $13,467 | $3,527 | 26.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 36 | $10,296 | $2,922 | 28.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 34 | 35 | $9,765 | $2,733 | 28.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $8,493 | $1,990 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 49 | 74 | $666.00 | $220.92 | 33.2% |
About Dr. Amjad Jalil, M.D
Dr. Amjad Jalil, M.D is a Hematology & Oncology healthcare provider based in Clairton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356391841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amjad Jalil, M.D has received a total of $2,063 in payments from pharmaceutical and medical device companies, with $121.62 received in 2024. These payments were reported across 130 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,844).
As a Medicare-enrolled provider, Jalil has provided services to 1,583 Medicare beneficiaries, totaling 2,853 services with total Medicare billing of $219,584. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Clairton, PA
- Active Since 05/12/2006
- Last Updated 10/09/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356391841
Products in Payments
- TECENTRIQ (Biological) $171.48
- Avastin (Biological) $127.39
- IMFINZI (Biological) $120.80
- KEYTRUDA (Biological) $91.49
- SUTENT (Drug) $90.42
- Abraxane (Drug) $82.79
- GAZYVA (Biological) $81.06
- ELIQUIS (Drug) $68.89
- Herceptin (Biological) $68.44
- XPOVIO (Drug) $60.54
- BOSULIF (Drug) $52.08
- ZYTIGA (Drug) $51.32
- OPDIVO (Biological) $47.61
- ADCETRIS (Biological) $45.90
- Perjeta (Biological) $41.80
- MEKINIST (Drug) $39.12
- VOTRIENT (Drug) $36.55
- VENCLEXTA (Biological) $34.98
- Enhertu (Drug) $28.68
- MONJUVI (Drug) $27.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.